Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

William H. Bradley MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Obstetrics and Gynecology
Division: Gynecologic Oncology
Program: Gynecological Oncology

Member of the Cancer Center


  • Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer. (Harold JA, Uyar D, Rader JS, Bishop E, Nugent M, Simpson P, Bradley WH) Int J Gynecol Cancer 2019 Jan;29(1):53-59 PMID: 30640684 01/15/2019    
  • Human factors and the 'next generation' airway trolley. (Chrimes N, Bradley WPL, Gatward JJ, Weatherall AD) Anaesthesia 2018 Dec 14 PMID: 30548998 12/15/2018    
  • Pharmacokinetics and clinical response to single agent rucaparib in a dialysis dependent patient with BRCA associated breast and recurrent ovarian cancer. (Harold JA, Free SC, Bradley WH) Gynecol Oncol Rep 2018 Nov;26:91-93 PMID: 30426062 PMCID: PMC6223187 11/15/2018    
  • Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. (Moore K, Colombo N, Scambia G, Kim BG, Oaknin A, Friedlander M, Lisyanskaya A, Floquet A, Leary A, Sonke GS, Gourley C, Banerjee S, Oza A, González-Martín A, Aghajanian C, Bradley W, Mathews C, Liu J, Lowe ES, Bloomfield R, DiSilvestro P) N Engl J Med 2018 12 27;379(26):2495-2505 PMID: 30345884 10/23/2018       21 Citations
  • Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. (von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L) Gynecol Oncol 2018 07;150(1):119-126 PMID: 29778506 05/21/2018    
  • IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients. (Choi J, Ye S, Eng KH, Korthauer K, Bradley WH, Rader JS, Kendziorski C) Stat Biosci 2017 Jun;9(1):1-12 PMID: 28966695 PMCID: PMC5617361 10/03/2017    
  • A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study. (Thaker PH, Brady WE, Lankes HA, Odunsi K, Bradley WH, Moore KN, Muller CY, Anwer K, Schilder RJ, Alvarez RD, Fracasso PM) Gynecol Oncol 2017 11;147(2):283-290 PMID: 28802766 PMCID: PMC5704992 08/15/2017       5 Citations
  • Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. (Cohn DE, Sill MW, Walker JL, O'Malley D, Nagel CI, Rutledge TL, Bradley W, Richardson DL, Moxley KM, Aghajanian C) Gynecol Oncol 2017 09;146(3):477-483 PMID: 28756871 PMCID: PMC5570536 08/02/2017       5 Citations
  • Pediatric Gynecologic Cancers. (Pommert L, Bradley W) Curr Oncol Rep 2017 Jul;19(7):44 PMID: 28501984 05/16/2017       2 Citations
  • A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. (Monk BJ, Brady MF, Aghajanian C, Lankes HA, Rizack T, Leach J, Fowler JM, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher EM, Anderson KS, Gottardo R, Bryan JK, Newkirk M, Manjarrez KL, Mannel RS, Hershberg RM, Coukos G) Ann Oncol 2017 May 01;28(5):996-1004 PMID: 28453702 PMCID: PMC5406764 04/30/2017       10 Citations
  • Integrated genomic and molecular characterization of cervical cancer. (Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis) Nature 2017 03 16;543(7645):378-384 PMID: 28112728 PMCID: PMC5354998 01/24/2017       141 Citations
  • Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. (von Gruenigen VE, Huang HQ, Beumer JH, Lankes HA, Tew W, Herzog T, Hurria A, Mannel RS, Rizack T, Landrum LM, Rose PG, Salani R, Bradley WH, Rutherford TJ, Higgins RV, Secord AA, Fleming G) Gynecol Oncol 2017 03;144(3):459-467 PMID: 28089376 PMCID: PMC5570471 01/17/2017       11 Citations
  • Endometrial carcinoma: The perioperative and long-term outcomes of robotic surgery in the morbidly obese. (Hinshaw SJ, Gunderson S, Eastwood D, Bradley WH) J Surg Oncol 2016 Dec;114(7):884-887 PMID: 27566529 10/30/2016       3 Citations
  • Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma. (Bradley WH, Eng K, Le M, Mackinnon AC, Kendziorski C, Rader JS) BMC Clin Pathol 2015;15:17 PMID: 26412982 PMCID: PMC4582729 09/29/2015    
  • Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer. (Eng KH, Hanlon BM, Bradley WH, Szender JB) Gynecol Oncol 2015 Nov;139(2):228-35 PMID: 26383827 PMCID: PMC4630152 09/19/2015       11 Citations
  • Pathway index models for construction of patient-specific risk profiles. (Eng KH, Wang S, Bradley WH, Rader JS, Kendziorski C) Stat Med 2013 Apr 30;32(9):1524-35 PMID: 23074142 PMCID: PMC3593986 10/18/2012       9 Citations
  • Recent advances in the surgical management of cervical cancer. (Zakashansky K, Bradley WH, Chuang L, Rahaman J, Dottino P) Mt Sinai J Med 2009 Dec;76(6):567-76 PMID: 20014423 12/17/2009       11 Citations
  • Patient clinical factors influencing use of hysterectomy in New York, 2001-2005. (Gretz H, Bradley WH, Zakashansky K, Nezhat F, Rahaman J, Chuang L, Bohren DL, Kreiger K, Rubin E, Sokolow A) Am J Obstet Gynecol 2008 Oct;199(4):349.e1-5 PMID: 18667172 08/01/2008       6 Citations
  • Effect of physician gender and specialty on utilization of hysterectomy in New York, 2001-2005. (Gretz H, Bradley WH, Zakashansky K, Nezhat F, Bohren DL, Kreiger K, Rubin E, Sokolow A) Am J Obstet Gynecol 2008 Oct;199(4):347.e1-6 PMID: 18639208 07/22/2008       9 Citations
  • Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation. (Bradley WH, Dottino PR, Rahaman J) Int J Gynecol Cancer 2008 Nov-Dec;18(6):1364-7 PMID: 18217973 01/26/2008       11 Citations
  • New techniques in radical hysterectomy. (Zakashansky K, Bradley WH, Nezhat FR) Curr Opin Obstet Gynecol 2008 Feb;20(1):14-9 PMID: 18197000 01/17/2008       29 Citations
  • Endometrial carcinoma expresses an increased cathepsin B/D ratio. (Bradley WH, Lima PH, Rodgers L, Blomquist CH, Downs LS) Gynecol Oncol 2008 Jan;108(1):84-9 PMID: 17980407 11/06/2007       7 Citations
  • A multi-institutional review of outcomes of endometrial stromal sarcoma. (Leath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA) Gynecol Oncol 2007 Jun;105(3):630-4 PMID: 17320937 02/27/2007       120 Citations
  • Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. (Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP) Gynecol Oncol 2004 Dec;95(3):632-6 PMID: 15581975 12/08/2004       47 Citations
  • Hysteroscopy and cytology in endometrial cancer. (Bradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF) Obstet Gynecol 2004 Nov;104(5 Pt 1):1030-3 PMID: 15516397 11/02/2004       41 Citations
  • Last update: 02/15/2019
    jenkins-FCD Prod-310 bff9d975ec7f2d302586822146c2801dd4449aad